Benefits Of Taking Part In Clinical Trials

Links shared publicly online about this topic.

  • 1,632
    total visits

Benefits Of Taking Part In Clinical Trials

medicalnewstoday.com

Patients with chronic heart failure who agree to take part in clinical trials have a better prognosis than those who do not, according to a study reported in the november european journal of he

View full resource at medicalnewstoday.com

Tags: Heart, Heart Disease, Heart Failure, Clinical Trial

  • Share

Most Recently Shared on November 2, 2009 at 1:26 pm By:

mnt_clinical MNT Clinical Trials

Benefits Of Taking Part In Clinical Trials: Patients with chronic heart failure who agree to take part in clini.. http://bit.ly/22H5wB

2 years ago...

Also Shared By:

MNT Cardiovascular MNT Cardiovascular

Bristol University | News from the University | School of Clinical Sciences

bristol.ac.uk — “Doctors from the University of Bristol are looking for volunteers who have recently been diagnosed with Type 1 diabetes to take part in an exercise study.View full resource at bristol.ac.uk

  • View Related
  • Share

Most Recently Shared on March 13, 2012 at 4:15 pm By:

DiabetesMine DiabetesMine Support

RT @jdrf: “Study hopes to find out the benefits of exercise in Type 1 #diabetes” Via University of Bristol. http://t.co/893rVl7Z #T1D #JDRF

1 month ago...

amednews: Practices can use EMRs to join more clinical trials :: March 12, 2012 ... American Medical News

ama-assn.org — “Practice Management - A column about keeping your practice in good healthView full resource at ama-assn.org

  • View Related
  • Share

Most Recently Shared on March 12, 2012 at 2:11 pm By:

ahier Brian Ahier Health IT

#EHR makes participation in clinical research easier http://t.co/ti6BZGnx via @amednews

1 month ago...

Any Laser Vision Clinics in Omaha Taking Part in Clinical Trials | LasikOmaha.com

lasikomaha.com — “Our Laser Vision Clinics - LaserVsion Correction in Omaha we are taking part in FDA Approved Trials, currently seeking candidates for new trial.View full resource at lasikomaha.com

  • View Related
  • Share

Most Recently Shared on November 11, 2011 at 6:50 pm By:

DrLanceKugler Lance Kugler Doctor, Surgeon, Ophthalmologist, and Physician

Our practice is conducting FDA-regulated clinical research on Scleral Spacing Procedure (SSP). - http://t.co/Fma9ptmw

5 months ago...

ScienceDirect - Parkinsonism & Related Disorders : What motivates Parkinson’s disease patients to enter clinical trials?

sciencedirect.com — “ScienceDirect - Parkinsonism & Related Disorders : What motivates Parkinson’s disease patients to enter clinical trials?View full resource at sciencedirect.com

  • View Related
  • Share

Most Recently Shared on October 22, 2011 at 3:45 pm By:

kieran_breen Kieran Breen Research

Occupational exposure in Parkinsonian disorders: http://t.co/RCHTUBGP #parkinsons

6 months ago...

Allied Health Professional Subscriptions Now Available | American Association of Clinical Endocrinologists

aace.com — “Allied Health Professional Subscriptions Now Available | American Association of Clinical EndocrinologistsView full resource at aace.com

  • View Related
  • Share

Most Recently Shared on September 14, 2011 at 3:01 pm By:

TheAACE AACE Medical Society

Are you an Allied Health Professional wanting to be a part of the AACE community? Check out what AACE has to offer. http://ow.ly/6udg4

7 months ago...

BBC News - Why do people take part in cancer clinical trials? - Jack's posterous

pharmagossip.posterous.com — “BBC News - Why do people take part in cancer clinical trials? - Jack's posterousView full resource at pharmagossip.posterous.com

  • View Related
  • Share

Most Recently Shared on August 7, 2011 at 6:19 am By:

pharmagossip Jack Friday - PharmaGossip Health Blog

BBC News - Why do people take part in cancer clinical trials? http://post.ly/2n93w

8 months ago...

NIH-funded study shows reduction in death for men with intermediate-grade prostate cancer, July 13, 2011 News Release - National Institutes of Health (NIH)

nih.gov — “Short-term hormone therapy given in combination with radiation therapy to men with early-stage prostate cancer increased their chances of living longer compared to treatment with radiation therapy alone, according to a clinical trial supported by the National Cancer Institute (NCI), part of the National Institutes of Health. Benefits of the combined treatment were limited mainly to patients with intermediate-risk disease and were not seen for men with low-risk prostate cancer, researchers say. TView full resource at nih.gov

  • View Related
  • Share

Most Recently Shared on July 13, 2011 at 10:25 pm By:

subatomicdoc Matthew Katz Oncologist, Radiation Oncologist, Physician, and Doctor

RT @NIHforHealth: News: NIH-funded study shows reduction in death for men with intermediate-grade prostate #cancer http://1.usa.gov/oa3tiF

9 months ago...

Implant helps control snoring | KING5.com Seattle

king5.com — “Implant helps control snoring | KING5.com SeattleView full resource at king5.com

  • View Related
  • Share

Most Recently Shared on July 12, 2011 at 4:14 pm By:

Swedish Swedish Healthcare System

@KING5Seattle story on @Swedish taking part in clinical trial looking at use of implantable stimulator for sleep apnea http://t.co/z50zDKS

9 months ago...

Taking part in a clinical trial advances knowledge, medical care - Harvard Health Publications

health.harvard.edu — “More than 18,000 clinical trials are underway right now in the United States, covering nearly every aspect of health and disease. Harvard Heart Letter editor P.J. Skerrett describes his experience as a volunteer in a clinical trial called TINSAL-T2D at the Joslin Diabetes Center in Boston.View full resource at health.harvard.edu

  • View Related
  • Share

Most Recently Shared on June 17, 2011 at 1:33 pm By:

HarvardHealth Harvard Health Medical School

Harvard Health's PJ Skerrett describes taking part in a clinical trial. 18,000 underway in the US. Join one? http://t.co/dZ9l4B8

10 months ago...

NIH study finds experimental drug benefits patients with rare type of cancer, June 6, 2011, News Release - National Institutes of Health (NIH)

nih.gov — “An experimental drug, cediranib, may benefit patients with a rare, slow-growing cancer called alveolar soft part sarcoma (ASPS), according to results from a clinical trial. The trial, carried out by scientists at the National Cancer Institute (NCI), part of the National Institutes of Health, showed that tumors shrank in more than 50 percent of ASPS patients who were treated with cediranib. These findings were presented at the American Society of Clinical Oncology annual meeting in Chicago on JunView full resource at nih.gov

  • View Related
  • Share

Most Recently Shared on June 6, 2011 at 7:22 pm By:

hrana Hisham Rana, MD Doctor and Physician

News: NIH study finds experimental drug benefits patients with rare type of cancer known as ASPS http://1.usa.gov/jkpD0M - #health

10 months ago...

Clinical Trial Confirms Benefit Of Targeted Lung Cancer Therapy

medicalnewstoday.com — “A drug that targets a specific type of lung cancer shows a dramatic response in more than half of the people who take it. The drug, called crizotinib, has been in clinical trials since 2006, and tView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on June 5, 2011 at 10:05 am By:

mnt_clinical MNT Clinical Trials Health News

Clinical Trial Confirms Benefit Of Targeted Lung Cancer Therapy http://mnt.to/3WLV #clinicaltrials

10 months ago...

Medical oncologists confirm benefits of crizotinib in ALK positive lung cancer

news-medical.net — “A drug that targets a specific type of lung cancer shows a dramatic response in more than half of the people who take it. The drug, called crizotinib, has been in clinical trials since 2006, and the results from the largest group of patients to take it within the first of these clinical trials are being presented at the annual meeting of the American Society of Clinical Oncology.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on June 4, 2011 at 5:42 am By:

LungCancer Lung Cancer OW OW Health

Medical oncologists confirm benefits of crizotinib in ALK positive lung cancer: A drug that targets a specific t... http://bit.ly/l6duZ8

10 months ago...

Benefit of targeted lung cancer therapy confirmed

eurekalert.org — “A drug that targets a specific type of lung cancer shows a dramatic response in more than half of the people who take it. The drug, called crizotinib, has been in clinical trials since 2006, and the results from the largest group of patients to take it within the first of these clinical trials are being presented at the annual meeting of the American Society of Clinical Oncology.View full resource at eurekalert.org

  • View Related
  • Share

Most Recently Shared on June 3, 2011 at 11:27 pm By:

LungCancer Lung Cancer OW OW Health

Benefit of targeted lung cancer therapy confirmed: ( University of Colorado Denver ) A drug that targets a speci... http://bit.ly/jDjgeT

10 months ago...

Benefit of targeted lung cancer therapy confirmed

sciencedaily.com — “A drug that targets a specific type of lung cancer shows a dramatic response in more than half of the people who take it. The drug, called crizotinib, has been in clinical trials since 2006, researchers are now reporting the results from the largest group of patients to take it within the first of these clinical trials.View full resource at sciencedaily.com

  • View Related
  • Share

Most Recently Shared on June 3, 2011 at 8:16 pm By:

medical_tweets medical_tweets Health News

Benefit of targeted lung cancer therapy confirmed: A drug that targets a specific type of lung cancer shows a dramatic.. http://dld.bz/acfTb

10 months ago...

Research/Clinical Trials - Breast Cancer Care, UMass Memorial Medical Center, Worcester, MA

umassmemorial.org — “We are at the forefront of some of the nation’s most promising research and treatment programs.View full resource at umassmemorial.org

  • View Related
  • Share

Most Recently Shared on May 20, 2011 at 6:25 pm By:

Advertisement